Skip to main content

Table 3 Treatment delivery, n = 18

From: A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

 

n (%)

Number of cycles

≤ 4

2 (11 %)

5-8

8 (44 %)

9-12

7 (39 %)

≥ 13

1 (6 %)

Median

8 cycles

Dose intensity*

Total number of cycles

146

Number of cycles at full dose

121 (83 %)

Number of cycles at reduced dose

25 (17 %)

Number of cycles delayed by ≥ 1 week

13 (9 %)

5-Fluorouracil dose intensity

98 %

Irinotecan dose intensity

95 %

Oxaliplatin dose intensity

98 %

  1. *Dose intensity is defined as the dose delivered divided by the full dose.